Elevated methylmalonic acid, but not vitamin B12, predicts all-cause mortality in hyperlipidemic adults: a prospective cohort study

ObjectivesDespite lipid-lowering therapy, patients with hyperlipidemia retain significant residual risk. This study investigated the independent and combined associations of serum methylmalonic acid (MMA), vitamin B12, and functional vitamin B12 status with all-cause mortality in this population.Met...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Qingtao Gong, Baiqiang Wang, Leiyang Li, Gongshuang Zhao, Chengzhi Li, Lianyue Ma, Hong Yang, Xiaojuan Zhang, Guipeng An, Chenghu Guo
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Frontiers Media S.A. 2026-01-01
Edice:	Frontiers in Nutrition
Témata:	all-cause mortality hyperlipidemia methylmalonic acid prognosis vitamin B12
On-line přístup:	https://www.frontiersin.org/articles/10.3389/fnut.2026.1742540/full
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!